Adipsin Antibodies

Santa Cruz Biotechnology features a diverse variety of Adipsin Antibodies for investigating adipsin's role in metabolic processes. Adipsin Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Adipsin, also known as complement factor D, is a serine protease that plays a crucial role in the activation of the alternative complement pathway and is involved in the regulation of adipocyte function. Adipsin is primarily produced by adipose tissue and has been implicated in obesity and insulin resistance, making it an important target for research in metabolic disorders. Research focused on adipsin can provide insights into the mechanisms of energy homeostasis and the pathophysiology of obesity-related diseases. Monoclonal adipsin antibodies enable precise detection and quantification of adipsin expression levels across different tissue types. Advanced research techniques utilizing adipsin antibodies help reveal new pathways in metabolic regulation. Investigating adipsin's molecular interactions provides valuable information about its role in maintaining metabolic balance. Santa Cruz Biotechnology monoclonal adipsin antibodies support researchers worldwide in advancing our understanding of metabolic health and disease mechanisms.